SCHEMBL30261987

SCHEMBL30261987

CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)CC

nearest known ligand 0.58

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ CRHR1 P34998 1/20 0.58
▸ CRHR2 Q13324 1/20 0.58
▸ CALCR P30988 4/20 0.57
▸ RXFP1 Q9HBX9 1/20 0.53
▸ PTH1R Q03431 3/20 0.51
▸ GLP1R P43220 4/20 0.51
▸ HCRTR1 O43613 1/20 0.50
▸ HCRTR2 O43614 1/20 0.50
▸ F2 P00734 1/20 0.49
▸ BACE1 P56817 1/20 0.49
▸ KEAP1 Q14145 1/20 0.49
▸ NPY1R P25929 1/20 0.49
▸ NPY2R P49146 1/20 0.49
▸ NPY4R P50391 1/20 0.49
▸ NPY5R Q15761 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30436221 0.90 CALCR (0.67) CRHR1CRHR2CALCRPTH1RGLP1R
SCHEMBL31182682 0.89 PTH1R (0.60) CRHR1CRHR2CALCRRXFP1PTH1R
SCHEMBL30136490 0.89 PTH1R (0.59) CRHR1CRHR2CALCRRXFP1PTH1R
Ishkdmqlgr SCHEMBL29843949 0.89 F2 (0.56) CRHR1CRHR2CALCRGLP1RHCRTR1
SCHEMBL31303964 0.88 PTH1R (0.59) CRHR1CRHR2CALCRRXFP1PTH1R
SCHEMBL29407403 0.88 PTH1R (0.59) CRHR1CRHR2CALCRRXFP1PTH1R
SCHEMBL31574194 0.88 CALCR (0.55) CRHR1CRHR2CALCRGLP1RHCRTR1
SCHEMBL29949418 0.88 CALCR (0.64) CRHR1CRHR2CALCRRXFP1PTH1R
SCHEMBL30262006 0.87 GLP1R (0.52) CRHR1CRHR2CALCRRXFP1GLP1R
SCHEMBL29777753 0.87 CALCR (0.51) CRHR1CRHR2CALCRRXFP1PTH1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230040544-A1 COMPOSITIONS AND METHODS FOR RESTORING AND MAINTAINING THE DYSTROPHIN-ASSOCIATED PROTEIN COMPLEX (DAPC) SAREPTA THERAPEUTICS, INC. 2023-02-09 — — US disclosed
Send feedback